BR112015018144A2 - composição de emulsão água/óleo farmacêutica com gotículas de óleo manométricas, método para fazer a mesma e método para tratar um paciente em necessidade de uma única dose alta de clopidogrel - Google Patents
composição de emulsão água/óleo farmacêutica com gotículas de óleo manométricas, método para fazer a mesma e método para tratar um paciente em necessidade de uma única dose alta de clopidogrelInfo
- Publication number
- BR112015018144A2 BR112015018144A2 BR112015018144A BR112015018144A BR112015018144A2 BR 112015018144 A2 BR112015018144 A2 BR 112015018144A2 BR 112015018144 A BR112015018144 A BR 112015018144A BR 112015018144 A BR112015018144 A BR 112015018144A BR 112015018144 A2 BR112015018144 A2 BR 112015018144A2
- Authority
- BR
- Brazil
- Prior art keywords
- clopidogrel
- doing
- patient
- treating
- need
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361761234P | 2013-02-06 | 2013-02-06 | |
| US61/761,234 | 2013-02-06 | ||
| US14/174,351 US9480680B2 (en) | 2013-02-06 | 2014-02-06 | Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery |
| US14/174,351 | 2014-02-06 | ||
| PCT/US2014/015097 WO2014124132A1 (en) | 2013-02-06 | 2014-02-06 | Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112015018144A2 true BR112015018144A2 (pt) | 2017-07-18 |
| BR112015018144A8 BR112015018144A8 (pt) | 2019-11-05 |
| BR112015018144B1 BR112015018144B1 (pt) | 2021-03-09 |
Family
ID=51297593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015018144-9A BR112015018144B1 (pt) | 2013-02-06 | 2014-02-06 | composição de emulsão água/óleo farmacêutica estável com gotículas de óleo manométricas, método para fazer a mesma e alta dose única de clopidogrel usada para tratar um paciente |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9480680B2 (pt) |
| EP (1) | EP2953613B1 (pt) |
| JP (1) | JP6552967B2 (pt) |
| KR (1) | KR102238292B1 (pt) |
| BR (1) | BR112015018144B1 (pt) |
| CA (1) | CA2911837C (pt) |
| ES (1) | ES2791417T3 (pt) |
| HK (1) | HK1218081A1 (pt) |
| WO (1) | WO2014124132A1 (pt) |
| ZA (1) | ZA201505195B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102238292B1 (ko) * | 2013-02-06 | 2021-04-09 | 징준 후앙 | 경구 및 비경구적 전달을 위한 클로피도그렐 유리 염기의 안정한 약학 조성물 |
| US20220218608A1 (en) * | 2019-05-10 | 2022-07-14 | Fordoz Pharma Corp. | Injectable polymer nanoparticle compositions of antithrombotic agents and methods thereof |
| CN111053738A (zh) * | 2019-10-16 | 2020-04-24 | 中国药科大学 | 氯吡格雷的注射剂型、制备方法及用途 |
| CN111228217B (zh) * | 2020-02-13 | 2022-02-11 | 广东药科大学 | 含氯吡格雷或其盐的磷脂复合物的亚微乳剂及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| GB0321256D0 (en) * | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
| EP1713812A1 (en) * | 2004-01-13 | 2006-10-25 | Zentiva, a.s. | New crystalline forms of clopidogrel hydrobromide and methods of their preparation |
| BRPI0608771A2 (pt) | 2005-05-10 | 2010-01-26 | Elan Pharma Int Ltd | formulações de clopidogrel em nanopartìcula |
| KR100783286B1 (ko) * | 2005-09-26 | 2007-12-06 | 주식회사종근당 | 클로피도그렐 우선성 광학이성체의 유리염기를 함유하는고형의 약제학적 조성물 |
| CN100367951C (zh) * | 2005-12-16 | 2008-02-13 | 石药集团恩必普药业有限公司 | 丁苯酞静脉乳剂及其应用 |
| WO2008060934A2 (en) * | 2006-11-14 | 2008-05-22 | Acusphere, Inc. | Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| KR20080055355A (ko) * | 2006-12-15 | 2008-06-19 | 에스케이케미칼주식회사 | 보관안정성이 우수한 클로피도그렐 함유 포접 복합체 |
| RU2470636C2 (ru) * | 2007-04-27 | 2012-12-27 | Сайдекс Фамэсьютиклз, Инк. | Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты) |
| WO2012122493A1 (en) * | 2011-03-10 | 2012-09-13 | Jina Pharmaceuticals, Inc. | Lipid based clopidogrel compositions, methods, and uses |
| CN102697724A (zh) * | 2012-06-07 | 2012-10-03 | 沈阳药科大学 | 氯吡格雷及其盐亚微乳注射液及其制备方法 |
| KR102238292B1 (ko) * | 2013-02-06 | 2021-04-09 | 징준 후앙 | 경구 및 비경구적 전달을 위한 클로피도그렐 유리 염기의 안정한 약학 조성물 |
-
2014
- 2014-02-06 KR KR1020157020587A patent/KR102238292B1/ko active IP Right Grant
- 2014-02-06 EP EP14748755.7A patent/EP2953613B1/en active Active
- 2014-02-06 WO PCT/US2014/015097 patent/WO2014124132A1/en active Application Filing
- 2014-02-06 US US14/174,351 patent/US9480680B2/en active Active
- 2014-02-06 ES ES14748755T patent/ES2791417T3/es active Active
- 2014-02-06 JP JP2015556260A patent/JP6552967B2/ja active Active
- 2014-02-06 BR BR112015018144-9A patent/BR112015018144B1/pt active IP Right Grant
- 2014-02-06 CA CA2911837A patent/CA2911837C/en active Active
-
2015
- 2015-07-20 ZA ZA2015/05195A patent/ZA201505195B/en unknown
-
2016
- 2016-06-02 HK HK16106254.0A patent/HK1218081A1/zh unknown
- 2016-09-29 US US15/279,848 patent/US9884016B2/en active Active
-
2018
- 2018-01-05 US US15/862,922 patent/US20180125782A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150112975A (ko) | 2015-10-07 |
| US20140227360A1 (en) | 2014-08-14 |
| WO2014124132A1 (en) | 2014-08-14 |
| HK1218081A1 (zh) | 2017-02-03 |
| CA2911837A1 (en) | 2014-08-14 |
| EP2953613B1 (en) | 2020-01-08 |
| US20180125782A1 (en) | 2018-05-10 |
| US20170014343A1 (en) | 2017-01-19 |
| CA2911837C (en) | 2022-05-31 |
| KR102238292B1 (ko) | 2021-04-09 |
| EP2953613A4 (en) | 2016-07-20 |
| ZA201505195B (en) | 2023-03-29 |
| US9480680B2 (en) | 2016-11-01 |
| BR112015018144A8 (pt) | 2019-11-05 |
| JP6552967B2 (ja) | 2019-07-31 |
| ES2791417T3 (es) | 2020-11-04 |
| JP2016507531A (ja) | 2016-03-10 |
| US9884016B2 (en) | 2018-02-06 |
| BR112015018144B1 (pt) | 2021-03-09 |
| EP2953613A1 (en) | 2015-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278018A (en) | Methods for the treatment or prevention of ophthalmological conditions | |
| BR112017005693A2 (pt) | método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica. | |
| BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015031475A2 (pt) | composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto. | |
| BR112016025997A2 (pt) | compostos para tratamento de doenças e lesões oftalmológicas, uma composição farmacêutica e uma formulação oftálmica | |
| BR112015023275A8 (pt) | biogênese de mirna em exossomos para diagnóstico e terapia. | |
| BR112015006996A2 (pt) | método para reduzir a quantidade de enxofre em uma composição que compreende enxofre, e, composição. | |
| SG11201509729YA (en) | Use of high dose pridopidine for treating huntington's disease | |
| BR112014030265A2 (pt) | composição farmacêutica líquida ou semissólida e método para tratar uma doença ou distúrbio neurológico ou de movimento. | |
| BR112016013502A2 (pt) | unidade de dosagem sólida que desintegra oralmente contendo um componente de estetrol. | |
| BR112015027861A2 (pt) | Dispensador de aplicação para pelo menos um componente | |
| DK4119569T3 (da) | Konjugerede antisense-forbindelser til anvendelse i behandling | |
| HK1199204A1 (en) | Composition for preventing or treating hangover | |
| EP3061452A4 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
| AP2016009209A0 (en) | Method and unit for treating an aqueous composition including at least one polymer | |
| EP2959903A4 (en) | MEDICAMENT FOR THE TREATMENT OF EYE DRESSING | |
| BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
| BR112014015598A8 (pt) | método para tratar uma porção de um poço, e, fluido de tratamento | |
| EP2982364A4 (en) | OIL-LIKE EMULSION COMPOSITION IN WATER | |
| DK3275452T3 (da) | Farmaceutisk sammensætning med silibinin | |
| SG11201509083YA (en) | Oil-in-water emulsion composition and surface treatment method using same | |
| HK1212630A1 (zh) | 油包水型乳化化妝品 | |
| CL2015000537A1 (es) | Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos. | |
| PL3041831T3 (pl) | Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/107 (2006.01), A61K 31/4365 (2006.01), A61K |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/02/2014, OBSERVADAS AS CONDICOES LEGAIS. |